Neutralizing antibodies to biological therapies: A "touch of gray" vs a "black and white" story

Neurology. 2007 Oct 2;69(14):1386-7. doi: 10.1212/01.wnl.0000282011.92098.68.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antibodies, Blocking / analysis
  • Antibodies, Blocking / blood
  • Antibodies, Blocking / immunology*
  • Antibodies, Monoclonal / immunology*
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antibody Specificity / immunology
  • Binding Sites, Antibody / immunology
  • Humans
  • Immunotherapy / methods*
  • Immunotherapy / standards
  • Multiple Sclerosis / drug therapy
  • Multiple Sclerosis / immunology*
  • Natalizumab

Substances

  • Antibodies, Blocking
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Natalizumab